BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/13/2025 11:47:53 AM | Browse: 146 | Download: 444
 |
Received |
|
2025-02-17 09:49 |
|
Peer-Review Started |
|
2025-02-18 00:05 |
|
First Decision by Editorial Office Director |
|
2025-03-11 06:03 |
|
Return for Revision |
|
2025-03-11 06:03 |
|
Revised |
|
2025-03-24 11:44 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-04-18 10:36 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-04-25 07:53 |
|
Articles in Press |
|
2025-04-25 07:53 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-05-27 02:52 |
|
Publish the Manuscript Online |
|
2025-06-13 11:47 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Review |
| Article Title |
Progress in the application of mesenchymal stem cells to attenuate apoptosis in diabetic kidney disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ping Nie, Wei Qin, Wei-Chen Nie and Bing Li |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Science and Technology Research Program of Jilin Provincial Department of Education |
JJKH20231218KJ |
| Project of the Jilin Provincial Administration of Traditional Chinese Medicine |
2024111 |
|
| Corresponding Author |
Bing Li, Department of Nephropathy, The Second Hospital of Jilin University, No. 218 Ziqiang Street, Changchun 130041, Jilin Province, China. li_bing2020@jlu.edu.cn |
| Key Words |
Apoptosis; Diabetic kidney disease; Mesenchymal stem cells; miRNA; Extracellular vesicles |
| Core Tip |
Diabetic kidney disease (DKD) represents a prevalent and serious complication of diabetes. Mesenchymal stem cells (MSCs) and their extracellular vesicles (MSC-EVs) show promise for treating DKD by regulating apoptosis; however, challenges such as a lack of standardization, hinder their clinical application. This review examines the research progress on the roles of MSCs and MSC-EVs in this disease. |
| Publish Date |
2025-06-13 11:47 |
| Citation |
Nie P, Qin W, Nie WC, Li B. Progress in the application of mesenchymal stem cells to attenuate apoptosis in diabetic kidney disease. World J Diabetes 2025; 16(6): 105711 |
| URL |
https://www.wjgnet.com/1948-9358/full/v16/i6/105711.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v16.i6.105711 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
